Emrix Sr30mg Capsule

0.00


Pack Size:                            7’s


Composition :            Cyclobenzaprine HCL


 

Pharmaceutical form:      Capsule


Brand Name: GETZ


 

Out of stock

Description

Emrix Sr30mg Capsule

Emrix Sr30mg Capsule (Cyclobenzaprine HCl) is a muscle) relaxant which relieves muscle spasm of local origin without interfering with muscle function. Emrix Sr 30mg Capsule is designated chemically as [3 & 5H&dibenzo) [a,d])cyclohepten& 5&ylidene) &NN&dimethylpropylamine hydrochloride. Emrix Sr 30mg Capsule molecular formula is C20H21N.HCl QUALITATIVE & QUANTITATIVE COMPOSITION Emrix Sr 30mg Capsule (Cyclobenzaprine HCl)) is available for oral administration) as: 1. Emrix Sr 30mg CapsuleCapsules)15mg Each capsule contains: Cyclobenzaprine hydrochloride as   extended & release pellets equivalent to Cyclobenzaprine hydrochloride USP…15mg 2. Emrix Sr 30mg Capsule Capsules 30mg Each capsule contains: Cyclobenzaprine hydrochloride as extended&release pellets equivalent to Cyclobenzaprine hydrochloride USP…30mg

Uses

Emrix Sr 30mg Capsule  (Cyclobenzaprine HCl  ) is indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated musculoskeletal conditions..

Side Effects

Major & minor side effects for Emrix Sr 30mg Capsule

  • Yellowing of skin or eyes rare
  • Blurred vision
  • Skin Rash rare
  • Dry mouth
  • Dizziness and Drowsiness
  • Nausea and vomiting
  • Headache
  • Constipation
  • Sweating

 

If any of these effects persist or worsen, tell your doctor or pharmacist promptly.

 When not to use

Emrix Sr 30mg Capsule is contraindicated in patients with known hypersensitivity to the drug. Emrix Sr 30mg Capsule is not recommended for use in patients with a known allergy to Emrix capsule SR 15 mg 14’s or any other inactive ingredients present along with the formulation. Emrix Sr 30mg Capsule is not recommended for use in patients taking monoamine oxidase inhibitors (MAOI) due to the increased risk of serious and life-threatening adverse effects. Your doctor may suggest maintaining a time gap of at least 14 days to start therapy with this medicine after discontinuing MAO inhibitors. Emrix Sr 30mg Capsule is not recommended for use in patients with hyperthyroidism (a condition where the thyroid gland produces too much thyroid hormones) due to the increased risk of worsening of the patient’s condition

Reviews

There are no reviews yet.

Be the first to review “Emrix Sr30mg Capsule”

Your email address will not be published. Required fields are marked *

0